Blueprint’s Phase II avapritinib sparks concerns on risk-benefit profile
AdvSM is a rare condition indicated by the uncontrolled accumulation of neoplastic mast cells (MCs) in various organs.
Trending menu:
-
![Evofem’s non-hormonal contraceptive Amphora scores attractive added benefit for bacterial infection prevention]()
Evofem’s non-hormonal contraceptive Amphora scores attractive added benefit for bacterial infection prevention
-
![Intercept’s Phase II-ready Ocaliva/bezafibrate has mixed experts views in primary biliary cholangitis]()
Intercept’s Phase II-ready Ocaliva/bezafibrate has mixed experts views in primary biliary cholangitis
-
![GlycoMimetics’ Phase III trial in relapsed/refractory AML protocol under review]()
GlycoMimetics’ Phase III trial in relapsed/refractory AML protocol under review
-
![Astellas expands into gene therapy with $3bn acquisition of Audentes]()
Astellas expands into gene therapy with $3bn acquisition of Audentes
-
![Evaluating NICE guidelines in regards to cannabis-based medicinal products targeting pain]()
Evaluating NICE guidelines in regards to cannabis-based medicinal products targeting pain
-
![Immunic in talks with Roche for Ocrevus use in planned Phase II/III multiple sclerosis combination]()
Immunic in talks with Roche for Ocrevus use in planned Phase II/III multiple sclerosis combination
Expert commentary & analysis from GlobalData
Annexon launches Phase 1b study of ANX-005 in combination with IVIG in subjects with Guillain-Barré syndrome
Blockbuster-to-be for depression flunks pivotal Phase III
Biogen’s aducanumab evokes debate on FDA approvability in Alzheimer’s disease
Exservan is approved by FDA to address major unmet ALS need
Most Read
Company releases
3DforScience Showed its Visual Solutions at ESMO Congress Barcelona
The European Society for Medical Oncology (ESMO) Congress took place Barcelona from 27 September to 1 October 2019. This was...
Enterprise API and Mobile Applications
SENTINEL 100 Tag
Sentinel 100 tags offer cost-effective piece-level tracking with long battery life and are based on low-cost and globally-standardised Bluetooth Low...
Vision Platform
SENTRY 500 FlightSafe
The SENTRY 500 FlightSafe® is a solution for shipment tracking on any mode of transport.
Company whitepapers
Understanding Sucrose: Matching Sucrose Quality to Functional Need
PfanstiehlTrehalose: A Powerful Excipient in the Formulation Toolbox
PfanstiehlSupporting the Pharmaceutical Industry, 21 CFR Part 11 Compliance Readiness
Malvern PanalyticalIKA Laboratory Equipment Brochure
Ika-WerkePrimary Cells Isolated from Healthy Human and Animal Tissues
Caltag MedsystemsImprove Endpoint Adjudication Efficiency with Ethical™ Adjudication®
EthicalIKA Case Study: Sustainable Processes for Textile Surfaces
Ika-WerkeCompany A-Z
Clinical Trials
Lilly launches trial to examine selpercatinib in NSCLC patients
Eli Lilly and Company has launched the LIBRETTO-431 Phase III clinical trial (NCT04194944) to examine selpercatinib (LOXO-292) for treatment-naïve RET fusion-positive non-small cell lung cancer...
AstraZeneca and Daiichi Sankyo report positive cancer drug trial data
ProQR doses first patient in Aurora trial of retinal disease therapy
Sanofi’s trial of sutimlimab meets primary and secondary endpoints
Amgen reports positive data in multiple myeloma study
Drug Development
Sangamo’s gene therapy shows promise in beta thalassemia study
Preliminary results from Sangamo Therapeutics’ Phase I/II THALES clinical trial of ST-400 have demonstrated a favourable profile of the gene therapy in treating transfusion-dependent beta...
Biohaven to continue testing troriluzole in Alzheimer’s patients
Ipsen places hold on paediatric patients in palovarotene’s studies
Sage Therapeutics’ SAGE-217 fails in late-stage depression trial
Acadia’s drug cuts psychosis relapse risk in dementia patients
Your recommended content
Supporting mental health in a business environment
Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report
Go Top